Achieving Sharp Peaks and High Sensitivity with Nexera X4

Significance of the topic

High-performance liquid chromatography (HPLC) remains a cornerstone technique for impurity profiling in pharmaceutical analysis. Minimizing peak broadening both inside and outside the column is critical to resolving structurally similar impurities and achieving low detection limits. Systems and software that reduce extra-column dispersion and accelerate method development directly improve assay sensitivity, throughput, and reliability in regulated and R&D laboratories.

Objectives and overview of the study

The study demonstrates how the Nexera X4 UHPLC system, together with LabSolutions MD method-development software, delivers sharper peaks, higher sensitivity, and faster optimization for impurity analysis. Hydrocortisone was used as a model small-molecule pharmaceutical to compare separation performance between Nexera X4 and a representative typical UHPLC system and to illustrate automated optimization of gradient, starting organic concentration, and column temperature.

Methodology and experimental conditions

• Analyte: Hydrocortisone (model compound for impurity separation).
• Mobile phase: Pump A — 0.1% formic acid in water; Pump B — acetonitrile.
• Column: Shim-pack Scepter C18-120, 50 mm × 2.1 mm I.D., 1.9 µm.
• Flow rate: 0.5 mL/min; injection volume: 1 µL (sample loop 15 µL); detection: UV 254 nm (SPD-M40 X4, STD cell).
• Gradient program: variable — initial organic (X) 5% or 10%, gradient to 95% at Y minutes then return; gradient times explored: 1.0, 1.2, 1.4 min.
• Column oven temperatures tested: 30, 40, 50 °C.

Used instrumentation

• Nexera X4 UHPLC system (low-dispersion design, Nexflow technology, end-surface-sealed high-pressure flow-line connections, tool-free fittings).
• Shim-pack Scepter C18-120 column (50 × 2.1 mm, 1.9 µm).
• SPD-M40 X4 UV detector (254 nm, standard cell).
• LabSolutions MD software for automated method development and evaluation.

Main results and discussion

• Low-dispersion system performance: Nexera X4’s internal design minimizes extra-column band broadening. This allowed the column to operate near its intrinsic efficiency, producing distinctly sharper peaks and higher peak heights versus a typical UHPLC system.
• Quantitative improvement: Under the baseline comparison (initial conc. 5%, 1.0 min gradient, 30 °C), Nexera X4 produced approximately 1.5× higher peak heights for the analyte/impurities versus the typical UHPLC system, and demonstrated improved resolution between closely eluting impurity peaks.
• Automated method screening: LabSolutions MD generated a comprehensive set of 18 method variants (2 initial concentrations × 3 gradient times × 3 temperatures) and ranked them using a simple quantitative metric: Evaluation Value = P × (sum of resolutions between adjacent peaks), where P is the number of detected peaks. This objective metric reduced reliance on operator intuition.
• Optimal conditions identified: The highest-ranked condition was initial organic 10%, gradient time 1.4 min, and column temperature 50 °C. Comparing chromatograms before and after optimization showed marked increases in resolution between impurities (example resolution factors rose from roughly ~1.0–1.3 to ~2.0–2.3), improving peak separation and detection confidence.
• Workflow efficiency: Automated schedule creation and numerical ranking substantially reduced manual effort and the need for advanced chromatographic expertise when screening multi-parameter method spaces.

Benefits and practical applications of the method

• Enhanced sensitivity: Reduced extra-column dispersion yields taller, narrower peaks, improving signal-to-noise and lowering limits of detection for impurity profiling.
• Improved separation power: The system enables more reliable resolution of structurally related impurities, supporting impurity identification and quantitation in pharmaceutical QC and R&D.
• Faster method development: LabSolutions MD automates experimental design, execution, and objective ranking of outcomes, shortening development time and reducing operator bias.
• Operational robustness: Nexflow design maintains low dispersion without reducing tubing bore, lowering blockage risk while preserving chromatographic performance; tool-free fittings improve usability and maintenance.

Future trends and potential applications

• Integration of automated method development with orthogonal detection (e.g., MS) and advanced data analytics will further accelerate impurity identification and profiling workflows.
• Broader adoption of low-dispersion hardware designs across LC platforms will raise baseline performance for routine QC assays and enable more widespread use of short UHPLC columns without sacrificing resolution.
• Machine-learning–based optimization could extend beyond grid screening to predict optimal gradients and temperature profiles from prior experiments, reducing the number of required runs.
• Miniaturization and higher-throughput multiplexing, combined with intelligent software, will support larger panels of formulation and degradation studies while maintaining sensitivity and resolution.

Conclusion

The combination of Nexera X4’s low-dispersion UHPLC hardware and LabSolutions MD’s automated method-development capabilities provides a practical route to sharper peaks, higher sensitivity, and faster, more objective optimization of impurity separations. For pharmaceutical impurity analysis, this approach improves detection limits and separation reliability while reducing the labor and expertise required for method development.

References

• Instrument, column and software names reported as used in the study: Nexera X4, LabSolutions MD, Shim-pack Scepter C18-120, SPD-M40 X4. (No external literature references were provided in the source document.)